文献速递胃肠外科

COLOR IV:腹腔镜右半结肠癌根治术体内与体外回结肠吻合的多中心随机对照试验

COLOR IV: a multicenter randomized clinical trial comparing intracorporeal and extracorporeal ileocolic anastomosis after laparoscopic right colectomy for colon cancer.
PubMed 文献 · Surg Endosc · 2024-12-28

COLOR IV 是一项国际多中心、随机、对照、开放标签、非劣效性试验,比较右半结肠癌腹腔镜右半结肠切除术后体内与体外回结肠吻合的安全性和有效性。主要终点为术后30天内吻合口漏发生率,主要次要终点为术后3年无病生存率,试验开始前将建立包括CT复核、病理评估及手术技术标准化与评估的综合质量保证方案。预期体内吻合的吻合口漏发生率和3年无病生存率与体外吻合相当,并可能加快术后恢复。

要点

  • 比较腹腔镜右半结肠切除术后体内与体外回结肠吻合的安全性和有效性。
  • 主要终点为术后30天内吻合口漏发生率。
  • 主要次要终点为术后3年无病生存率。

核心结论

  • 预期体内回结肠吻合的吻合口漏发生率和3年无病生存率与体外吻合相当,并可能加快术后恢复。

研究设计与样本

  • 国际、多中心、随机、对照、开放标签、非劣效性试验,比较右半结肠癌腹腔镜右半结肠切除术后体内与体外回结肠吻合。

关键数值与推荐

  • 主要终点为术后30天内吻合口漏发生率。
  • 主要次要终点为术后3年无病生存率。
  • 试验开始前建立综合质量保证方案,包括CT复核、病理评估及手术技术标准化与评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Right-sided colon cancer is a prevalent malignancy. The standard surgical treatment for this condition is laparoscopic right hemicolectomy, with ileocolic anastomosis being a crucial step in the procedure. Recently, intracorporeal ileocolic anastomosis has garnered attention for its minimally invasive benefits. However, there remains a paucity of rigorously designed, large-scale, international multicenter randomized controlled trials to definitively assess the safety and efficacy of intracorporeal ileocolic anastomosis in laparoscopic right hemicolectomy for right-sided colon cancer. METHODS: This study is an international, multicenter, randomized, controlled, open-label, non-inferiority trial designed to compare the safety and efficacy of intracorporeal versus extracorporeal ileocolic anastomosis in patients with right-sided colon cancer undergoing right hemicolectomy. The primary endpoint is the anastomotic leakage rate within 30 days post-surgery. The main secondary endpoint is the 3-year disease-free survival rate post-surgery. A comprehensive quality assurance protocol will be established before the trial begins, including CT review, pathological evaluation, and the standardization and assessment of surgical techniques. DISCUSSION: This study aims to evaluate the safety and efficacy of intracorporeal ileocolic anastomosis following right hemicolectomy in patients with right-sided colon cancer. The anticipated outcome is that intracorporeal ileocolic anastomosis will show an anastomotic leakage rate and a 3-year disease-free survival rate comparable to those of extracorporeal anastomosis, while offering the added benefit of faster postoperative recovery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wu S, Wei P, Gao J, et al. COLOR IV: a multicenter randomized clinical trial comparing intracorporeal and extracorporeal ileocolic anastomosis after laparoscopic right colectomy for colon cancer. Surg Endosc. 2024. PMID: 39733171. doi:10.1007/s00464-024-11412-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。